Skip to content

Clinical trials

Recruiting Diabetes Mellitus, Type 2 trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Status: Recruiting Country / region: Germany Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20121
20151
20181
20211
20231
20243
202511
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Novo Nordisk A/S4
Eli Lilly and Company3
German Diabetes Center2
German Institute of Human Nutrition2
Heinrich-Heine University, Duesseldorf2
Ascletis Pharma (China) Co., Limited1
Bayer1
Boehringer Ingelheim1
FIDAM RDC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 234
Obesity12
Overweight7
Diabetes Mellitus5
Diabetes Mellitus, Type 14
Heart Failure4
Hypertension4
Cardiovascular Diseases3
Diabetes Complications2
Fatty Liver2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.